Intuitive Surgical, Inc. (NASDAQ:ISRG) is Triodos Investment Management BV's 4th Largest Position

Triodos Investment Management BV lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 91,037 shares of the medical equipment provider's stock after selling 12,700 shares during the quarter. Intuitive Surgical comprises 3.8% of Triodos Investment Management BV's portfolio, making the stock its 4th biggest holding. Triodos Investment Management BV's holdings in Intuitive Surgical were worth $47,518,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in ISRG. Norges Bank purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $2,401,493,000. Blair William & Co. IL increased its holdings in Intuitive Surgical by 0.9% in the 4th quarter. Blair William & Co. IL now owns 468,880 shares of the medical equipment provider's stock valued at $244,737,000 after acquiring an additional 4,101 shares during the last quarter. NEOS Investment Management LLC raised its position in shares of Intuitive Surgical by 24.4% during the 4th quarter. NEOS Investment Management LLC now owns 44,979 shares of the medical equipment provider's stock valued at $23,477,000 after buying an additional 8,832 shares in the last quarter. UniSuper Management Pty Ltd lifted its holdings in shares of Intuitive Surgical by 8.8% in the 4th quarter. UniSuper Management Pty Ltd now owns 59,354 shares of the medical equipment provider's stock valued at $30,980,000 after acquiring an additional 4,793 shares during the last quarter. Finally, Sava Infond d.o.o. purchased a new position in Intuitive Surgical in the fourth quarter worth about $4,979,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Remove Ads

Intuitive Surgical Trading Up 0.3 %

Shares of ISRG traded up $1.56 during mid-day trading on Tuesday, hitting $496.83. The company's stock had a trading volume of 578,180 shares, compared to its average volume of 1,526,496. The company's 50-day moving average is $554.33 and its 200-day moving average is $532.98. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $176.96 billion, a price-to-earnings ratio of 77.26, a PEG ratio of 5.85 and a beta of 1.43.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. Company insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several analyst reports. Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target for the company. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.